Device Trial Radar · NCT01437163
Treatment of Androgenetic Alopecia in Males and Females
Last checked: Nov 20, 2026Latest source record: Jul 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
88
Actual
Start
Sep 2011
Primary completion
Aug 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Apira Science, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 20, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy system configured in a novel product called the TopHat 655 system, for promoting hair growth in males and females diagnosed with androgenetic alopecia of the head.
Conditions
- Androgenetic Alopecia
Interventions
TopHat 655 rejuvenation systemDevice
TopHat 655 system is to be applied every other day for 16 weeks for a pre-programmed time period
Laser and/or Light Hair Rejuvenation SystemDevice
A red incandescent light source replaces all lasers and light emitting diodes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Increase of Terminal Hairs from Pre-treatment, Baseline CountTime frame: After 16 weeks of therapy
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Adolfo Fernandez-Obregon, MD
Hoboken, New Jersey
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.